NCT01103167

Body Composition Monitor in Hemodialysis Patients

The Association Between Body Composition and Biomarkers in Hemodialysis Patients

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 160 (estimated)
• Sponsor: Gachon University Gil Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Control of volume status is a pivotal issue in haemodialysis therapy. Objective and practical management for maintaining normovolemia is needed. The investigators hypothesized that intervention of volume status with the body composition monitor (BCM) may improved hemodynamic parameters and biomarkers in hemodialysis patients.

Detailed description

The investigators will assess BCM in enrolled hemodialysis patients by 4 weeks for 16 weeks During the former 8-week intervention period, The investigators will adjust patients' volume status according to the results of BCM. During the latter 8-week observational period, The investigators will evaluate the changes of patients' hemodynamic parameters and biomarkers.

Conditions

• End Stage Renal Disease

Interventions

Type	Name	Description
BEHAVIORAL	control of ultrafiltration	During the interventional period, dry weight of patients will be adjusted according to the results of body composition.

Timeline

• Start date: 2010-04-01
• Primary completion: 2010-10-01
• Completion: 2010-12-01
• First posted: 2010-04-14
• Last updated: 2010-04-14

Locations

1 site across 1 country: South Korea